IL146969A0 - Mono- and disubstituted 3-propyl gamma-aminobutyric acids - Google Patents

Mono- and disubstituted 3-propyl gamma-aminobutyric acids

Info

Publication number
IL146969A0
IL146969A0 IL14696900A IL14696900A IL146969A0 IL 146969 A0 IL146969 A0 IL 146969A0 IL 14696900 A IL14696900 A IL 14696900A IL 14696900 A IL14696900 A IL 14696900A IL 146969 A0 IL146969 A0 IL 146969A0
Authority
IL
Israel
Prior art keywords
disubstituted
mono
aminobutyric acids
propyl gamma
gamma
Prior art date
Application number
IL14696900A
Other languages
English (en)
Original Assignee
Warner Lambert Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Warner Lambert Co filed Critical Warner Lambert Co
Publication of IL146969A0 publication Critical patent/IL146969A0/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/34—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton containing six-membered aromatic rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/08—Antiepileptics; Anticonvulsants
    • A61P25/10—Antiepileptics; Anticonvulsants for petit-mal
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A61P29/02—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID] without antiinflammatory effect
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/06—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton
    • C07C229/08—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated having only one amino and one carboxyl group bound to the carbon skeleton the nitrogen atom of the amino group being further bound to hydrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/20—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by halogen atoms or by nitro or nitroso groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/04—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated
    • C07C229/22—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and saturated the carbon skeleton being further substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/30—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being acyclic and unsaturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/32—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being unsaturated and containing rings other than six-membered aromatic rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
    • C07B2200/00—Indexing scheme relating to specific properties of organic compounds
    • C07B2200/07—Optical isomers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/02—Systems containing only non-condensed rings with a three-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/04—Systems containing only non-condensed rings with a four-membered ring
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Psychiatry (AREA)
  • Anesthesiology (AREA)
  • Psychology (AREA)
  • Hospice & Palliative Care (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
IL14696900A 1999-06-10 2000-05-31 Mono- and disubstituted 3-propyl gamma-aminobutyric acids IL146969A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US13848599P 1999-06-10 1999-06-10
PCT/US2000/015070 WO2000076958A2 (en) 1999-06-10 2000-05-31 Mono- and disubstituted 3-propyl gamma-aminobutyric acids

Publications (1)

Publication Number Publication Date
IL146969A0 true IL146969A0 (en) 2002-08-14

Family

ID=22482232

Family Applications (2)

Application Number Title Priority Date Filing Date
IL14696900A IL146969A0 (en) 1999-06-10 2000-05-31 Mono- and disubstituted 3-propyl gamma-aminobutyric acids
IL146969A IL146969A (en) 1999-06-10 2001-12-06 Transformed acids - in the cell of amino acids - gamma and drugs containing them

Family Applications After (1)

Application Number Title Priority Date Filing Date
IL146969A IL146969A (en) 1999-06-10 2001-12-06 Transformed acids - in the cell of amino acids - gamma and drugs containing them

Country Status (43)

Country Link
EP (1) EP1192125B9 (de)
JP (1) JP3904452B2 (de)
KR (1) KR100694735B1 (de)
CN (2) CN1196671C (de)
AP (1) AP1397A (de)
AR (1) AR033335A1 (de)
AT (1) ATE419231T1 (de)
AU (1) AU776723C (de)
BG (1) BG65561B1 (de)
BR (1) BR0011727A (de)
CA (2) CA2374755C (de)
CO (1) CO5200791A1 (de)
CR (1) CR6529A (de)
CU (1) CU23101A3 (de)
CY (1) CY1108827T1 (de)
CZ (2) CZ301608B6 (de)
DE (1) DE60041256D1 (de)
DK (1) DK1192125T3 (de)
DZ (1) DZ3253A1 (de)
EA (1) EA004398B1 (de)
EE (1) EE200100672A (de)
ES (1) ES2317839T3 (de)
GE (1) GEP20074142B (de)
HK (2) HK1046401B (de)
HR (1) HRP20020025A2 (de)
HU (1) HUP0201601A3 (de)
IL (2) IL146969A0 (de)
IS (1) IS6181A (de)
MA (1) MA26804A1 (de)
ME (1) MEP44808A (de)
MX (1) MXPA01012319A (de)
NO (2) NO327746B1 (de)
NZ (1) NZ515668A (de)
OA (1) OA11962A (de)
PE (1) PE20010285A1 (de)
PT (1) PT1192125E (de)
RS (2) RS20090257A (de)
SI (1) SI1192125T1 (de)
SK (2) SK287247B6 (de)
TR (1) TR200103587T2 (de)
UA (1) UA72519C2 (de)
WO (1) WO2000076958A2 (de)
ZA (1) ZA200109711B (de)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7164034B2 (en) 1999-06-10 2007-01-16 Pfizer Inc. Alpha2delta ligands for fibromyalgia and other disorders
US6620829B2 (en) * 2000-10-17 2003-09-16 Warner-Lambert Company Method of treating noninflammatory cartilage damage
ES2296956T5 (es) * 2001-06-11 2011-07-12 Xenoport, Inc. Profármacos de análogos de gaba, composiciones y sus usos.
US8048917B2 (en) 2005-04-06 2011-11-01 Xenoport, Inc. Prodrugs of GABA analogs, compositions and uses thereof
ITMI20011308A1 (it) 2001-06-21 2002-12-21 Nicox Sa Farmaci per il dolore cronico
JP2005521664A (ja) 2002-01-31 2005-07-21 ワーナー−ランバート カンパニー リミティド ライアビリティー カンパニー 耳鳴を治療するためのアルファ２デルタ・リガンド
NI200300043A (es) * 2002-03-28 2003-11-05 Warner Lambert Co AMINOACIDOS CON AFINIDAD POR LA PROTEINA a2DELTA.
US20030225149A1 (en) 2002-04-30 2003-12-04 Blazecka Peter G. Process for preparing highly functionalized gamma-butyrolactams and gamma-amino acids
US7071339B2 (en) 2002-08-29 2006-07-04 Warner Lambert Company Llc Process for preparing functionalized γ-butyrolactones from mucohalic acid
WO2004054566A1 (en) 2002-12-13 2004-07-01 Warner-Lambert Company Llc Pregabalin derivatives for the treatment of fibromyalgia and other disorders
CA2451267A1 (en) 2002-12-13 2004-06-13 Warner-Lambert Company Llc Pharmaceutical uses for alpha2delta ligands
DE60332387D1 (de) 2002-12-13 2010-06-10 Warner Lambert Co Alpha-2-delta-ligand zur behandlung vonsymptomen der unteren harnwege
CA2508297A1 (en) * 2002-12-13 2004-07-01 Warner-Lambert Company Llc Pregabalin and derivates thereof for the treatment of fibromyalgia and other related disorders
ITMI20022658A1 (it) 2002-12-17 2004-06-18 Nicox Sa Farmaci per il dolore cronico.
WO2005002585A1 (en) * 2003-07-02 2005-01-13 Warner-Lambert Company Llc Combination of an allosteric inhibitor of matrix metalloproteinase-13 and a ligand to an alpha-2-delta receptor
CN1849153A (zh) 2003-09-12 2006-10-18 辉瑞大药厂 含有α－2－δ配体和5－羟色胺/去甲肾上腺素重摄取抑制剂的组合物
EP1670750A1 (de) 2003-09-25 2006-06-21 Warner-Lambert Company LLC Prodrugs von aminosäuren mit affinität für das alpha2delta-protein
EA200600467A1 (ru) * 2003-09-25 2006-08-25 Уорнер-Ламберт Компани Ллс АМИНОКИСЛОТЫ СО СРОДСТВОМ К α2δ-БЕЛКУ
WO2006043171A2 (en) * 2004-10-23 2006-04-27 Warner-Lambert Company Llc Methods of using alpha2delta-1 selective compounds
EP1926710B1 (de) * 2005-09-15 2014-11-12 UCB Pharma S.A. 4-Substituierte Pyrrolidin-2-one und ihre Verwendung
US20070141684A1 (en) * 2005-12-21 2007-06-21 Pfizer Inc Preparation of gamma-amino acids having affinity for the alpha-2-delta protein
AR061728A1 (es) * 2006-06-30 2008-09-17 Pfizer Prod Inc Composicion para tratamiento usando compuestos selectivos alfa-2-delta-1
RS51940B (en) 2006-12-22 2012-02-29 Recordati Ireland Limited Combined TH2δ LIGANAD THERAPY AND NSAID FOR LOWER URINARY TRACT DISORDERS
WO2009136375A1 (en) * 2008-05-08 2009-11-12 Pfizer Inc Treatment of interstitial cystitis
JP5815552B2 (ja) 2009-12-08 2015-11-17 ケース ウェスタン リザーブ ユニバーシティＣａｓｅ Ｗｅｓｔｅｒｎｒｅｓｅｒｖｅ Ｕｎｉｖｅｒｓｉｔｙ 眼疾患を治療する化合物および方法
CN101914031B (zh) * 2010-07-30 2013-08-28 中国广州分析测试中心 普瑞巴林衍生物及其应用
FI3364958T3 (fi) * 2015-10-23 2023-04-06 Navitor Pharm Inc Sestriinin ja gator2:n vuorovaikutuksen modulaattoreita ja niiden käyttötapoja

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US6197819B1 (en) * 1990-11-27 2001-03-06 Northwestern University Gamma amino butyric acid analogs and optical isomers
WO1992009560A1 (en) * 1990-11-27 1992-06-11 Northwestern University Gaba and l-glutamic acid analogs for antiseizure treatment
JP3856816B2 (ja) * 1992-05-20 2006-12-13 ノースウェスターン ユニヴァーシティ 抗発作治療用のｇａｂａ及びｌ−グルタミン酸類縁体
US5637767A (en) * 1995-06-07 1997-06-10 Warner-Lambert Company Method of making (S)-3-(aminomethyl)-5-methylhexanoic acid
CN1094757C (zh) * 1996-07-24 2002-11-27 沃尼尔·朗伯公司 用于治疗疼痛的异丁基γ－氨基丁酸及其衍生物
WO1998017627A1 (en) * 1996-10-23 1998-04-30 Warner-Lambert Company Substituted gamma aminobutyric acids as pharmaceutical agents
DE69834204T2 (de) * 1997-10-27 2007-03-29 Warner-Lambert Co. Llc Zyklische aminosäuren und deren derivate als arzneimittel

Also Published As

Publication number Publication date
CZ301608B6 (cs) 2010-04-28
BG65561B1 (bg) 2008-12-30
AU776723B2 (en) 2004-09-16
OA11962A (en) 2006-04-17
JP2003502308A (ja) 2003-01-21
AU5311900A (en) 2001-01-02
SK287399B6 (sk) 2010-08-09
MEP44808A (en) 2011-02-10
DK1192125T3 (da) 2009-02-16
EP1192125B1 (de) 2008-12-31
SI1192125T1 (sl) 2009-04-30
NO20091094L (no) 2001-12-05
CA2374755C (en) 2010-03-30
CN1355784A (zh) 2002-06-26
CN1310872C (zh) 2007-04-18
CY1108827T1 (el) 2014-04-09
DZ3253A1 (fr) 2000-12-21
CA2689997A1 (en) 2000-12-21
HRP20020025A2 (en) 2003-12-31
NZ515668A (en) 2004-02-27
NO20015949D0 (no) 2001-12-05
AP2002002388A0 (en) 2002-03-31
AU776723C (en) 2005-06-02
CN1196671C (zh) 2005-04-13
IL146969A (en) 2008-03-20
NO20015949L (no) 2001-12-05
EP1192125A2 (de) 2002-04-03
SK17642001A3 (sk) 2002-10-08
AP1397A (en) 2005-04-19
PT1192125E (pt) 2009-03-05
WO2000076958A3 (en) 2001-04-12
CN1660779A (zh) 2005-08-31
WO2000076958A2 (en) 2000-12-21
GEP20074142B (en) 2007-07-10
KR100694735B1 (ko) 2007-03-14
YU87001A (sh) 2004-07-15
ZA200109711B (en) 2003-03-20
BR0011727A (pt) 2002-03-05
HUP0201601A3 (en) 2002-11-28
CZ20014285A3 (cs) 2002-07-17
CZ300834B6 (cs) 2009-08-19
PL352431A1 (en) 2003-08-25
SK287247B6 (sk) 2010-04-07
HK1076626A1 (en) 2006-01-20
TR200103587T2 (tr) 2002-04-22
AR033335A1 (es) 2003-12-17
CU23101A3 (es) 2005-12-20
KR20020009631A (ko) 2002-02-01
NO327746B1 (no) 2009-09-14
EA200101134A1 (ru) 2002-06-27
ATE419231T1 (de) 2009-01-15
MA26804A1 (fr) 2004-12-20
ES2317839T3 (es) 2009-05-01
EA004398B1 (ru) 2004-04-29
IS6181A (is) 2001-11-28
RS50352B (sr) 2009-11-10
EP1192125B9 (de) 2009-09-16
HK1046401A1 (en) 2003-01-10
HK1046401B (zh) 2005-12-02
RS20090257A (en) 2010-03-02
JP3904452B2 (ja) 2007-04-11
CO5200791A1 (es) 2002-09-27
MXPA01012319A (es) 2002-07-22
CA2374755A1 (en) 2000-12-21
EE200100672A (et) 2003-02-17
UA72519C2 (en) 2005-03-15
PE20010285A1 (es) 2001-03-22
DE60041256D1 (de) 2009-02-12
BG106292A (en) 2002-05-31
HUP0201601A2 (en) 2002-10-28
CR6529A (es) 2003-11-25

Similar Documents

Publication Publication Date Title
IL146969A0 (en) Mono- and disubstituted 3-propyl gamma-aminobutyric acids
SG93823A1 (en) Aryl-acrylic acid esters
PL340819A1 (en) Dipeptidic nitriles
HUP0300301A3 (en) New aminopropylphosphinic acids
GB9724728D0 (en) Improved club
ZA9810073B (en) Dipeptide nitriles
GB2348924B (en) Fastener
EP0986296A4 (de) Fettsäureelongase
GB2325170B (en) Practice driving device for golfers
GB9926805D0 (en) Diagnostic methods
TW385640U (en) Fastener
GB9704876D0 (en) Diagnostic methods
GB9812674D0 (en) Nucleic acids
EP1218276A4 (de) Sauschwanzbefestiger
EP0833947A4 (de) Verschiedene presenilin-2 gene
GB0026973D0 (en) Thjreaded fasteners
GB9907836D0 (en) Carbonylation process
GB2369664B (en) Fastener
GB9707716D0 (en) Nasogastric tonometry
GB9920224D0 (en) Nucleic acids
TW317277U (en) Row type fastener
GB9623694D0 (en) Automated golf driving range
GB9910034D0 (en) Fastener
TW443708U (en) Fastener
TW433418U (en) Fastener

Legal Events

Date Code Title Description
FF Patent granted
KB Patent renewed